Constellation Pharmaceuticals' Series B - II Round

Constellation Pharmaceuticals raised a round of funding on June 10, 2010. Investors include SR One.

Constellation Pharmaceuticals is a biopharmaceutical company dedicated to the development of therapeutics in the emerging field of Epigenetics, a new field of science involving selective regulators th…

Articles about Constellation Pharmaceuticals' Series B - II Round: